NCT04887064 - Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 22, 2021

Primary Completion Date

March 9, 2022

Study Completion Date

March 9, 2022

Conditions

Hepatic Impairment

Interventions

DRUG

Sotorasib

Sotorasib will be administered as an oral tablet.

Trial Locations (5)

Orlando Clinical Research Center, Orlando

Clinical Pharmacology Of Miami LLC, Miami

American Research Corporation, San Antonio

Pinnacle Clinical Research - San Antonio, San Antonio

Orange County Research Center, Tustin